-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Harvard Bioscience Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2010 to 2023.
- Harvard Bioscience Inc Amortization of Intangible Assets for the quarter ending September 30, 2024 was $1.33M, a 1.98% decline year-over-year.
- Harvard Bioscience Inc Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $5.39M, a 6.64% decline year-over-year.
- Harvard Bioscience Inc annual Amortization of Intangible Assets for 2023 was $5.53M, a 9.75% decline from 2022.
- Harvard Bioscience Inc annual Amortization of Intangible Assets for 2022 was $6.12M, a 4.83% increase from 2021.
- Harvard Bioscience Inc annual Amortization of Intangible Assets for 2021 was $5.84M, a 2.28% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)